Isoxazoles and their use as inhibitors of erk

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 413/04 (2006.01) A61K 31/422 (2006.01) A61K 31/433 (2006.01) A61K 31/439 (2006.01) A61K 31/454 (2006.01) A61K 31/4725 (2006.01) A61K 31/496 (2006.01) A61K 31/497 (2006.01) A61P 35/00 (2006.01) C07D 413/14 (2006.01) C07D 417/14 (2006.01)

Patent

CA 2422376

Described herein are compounds that are useful as protein kinase inhibitors, especially inhibitors of ERK, having the formula (I) wherein Ht is an optionally substituted heteroaryl ring selected from pyrrol-3-yl, pyrazol-3- yl, [1,2,3]triazol-4-yl, or tetrazol-5-yl, and A-B is N-O or O-N. The compounds are useful for treating diseases in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.

L'invention concerne des composés utiles comme inhibiteurs de la protéine kinase, notamment comme inhibiteurs d'ERK. Ces composés présentent une formule (I) dans laquelle Ht est un noyau hétéroaryle éventuellement substitué sélectionné dans le groupe constitué par pyrrol-3-yle, pyrazol-3-yle, [1,2,3]triazol-4-yle, ou tétrazol-5-yle; et A-B est N-O ou O-N. Ces composés peuvent être utilisés pour traiter, chez les mammifères, des maladies qui sont atténuées par un inhibiteur de la protéine kinase, en particulier des maladies telles que le cancer, les troubles inflammatoires, la resténose, et les maladies cardiovasculaires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Isoxazoles and their use as inhibitors of erk does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Isoxazoles and their use as inhibitors of erk, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoxazoles and their use as inhibitors of erk will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1755994

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.